San Diego’s Amplyx Raises $67M to Advance New Anti-Fungal Drug

San Diego’s Amplyx Raises $67M to Advance New Anti-Fungal Drug – Xconomy

XconomyAfter completing an early stage evaluation of its broad-spectrum anti-fungal drug, San Diego’s Amplyx Pharmaceuticals said Wednesday it has raised $67 million in a Series C financing round led by a new investor, Sofinnova Venture Partners. Ciara … …read more Source:: San Diego News By Google News

from WordPress http://ift.tt/2vhH8UI
via IFTTT